Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

UCSF developing AI to speed prostate cancer diagnosis

By Author Proscia | March 3, 2020

The University of California San Francisco tapped pathology software company Proscia to jointly develop and test artificial intelligence solutions that could improve physicians’ speed and accuracy in diagnosing prostate cancer.

Our website uses cookies. By using this site, you agree to its use of cookies.